Johnson & Johnson Opens New Global Services Center In Tampa, Florida

06:54 EDT 19 Oct 2016 | PR Newswire

TAMPA, Fla., Oct. 19, 2016 /PRNewswire/ -- Today Johnson & Johnson (NYSE: JNJ) officially opened the doors of the new Johnson & Johnson Global Services delivery center in Tampa, Florida, fulfilling the commitment the company announced in August 2015 to establish their best-in-class site in the state.

The new 88.5 thousand square foot building is a state-of-the-art facility that opens with 240 Johnson & Johnson Global Services employees. By 2020 the company expects to locate 540 people in the center. Johnson & Johnson chose Tampa as its North America hub due to the availability of highly educated talent in the fields of Finance, Operations, Information Technology, Procurement and Human Resources.

"Today we celebrate opening this new center as the latest advancement in the proud history of the world's largest and most broadly-based health care company," said Erin Champlin, Vice President of Johnson & Johnson Global Services. "This new center expands our strong business presence within the state of Florida and we are excited to be a more active member of this vibrant Tampa community."

About Johnson & Johnson Caring for the world, one person at a time, inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 126,900 employees at more than 250 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

Logo -

To view the original version on PR Newswire, visit:

SOURCE Johnson & Johnson


More From BioPortfolio on "Johnson & Johnson Opens New Global Services Center In Tampa, Florida"

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Antiretroviral therapy
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...